Navigation Links
Medisafe 1 Technologies to Present Syringe Locking-Device Technology at HealthAchieve Conference
Date:11/4/2010

Medisafe 1 Technologies to Present Syringe Locking-Device Technology at HealthAchieve Conference -- JERUSALEM, November 4, 2010 /PRNewswire-FirstCall/ --


Advanced Search Search

  
Close
  1. Send a release
  2. Member sign in
  3. Become a member
  4. For journalists
  5. Global sites
PR Newswire: news distribution, targeting and monitoring
  1. Products & Services
  2. Knowledge Center
  3. Browse News Releases
  4. Contact PR Newswire
Banking & Financial Services, Health Care & Hospitals, Medical Equipment, Medical Pharmaceuticals, New Products & Services, Trade Show News Click to view news release full screen  

Medisafe 1 Technologies to Present Syringe Locking-Device Technology at HealthAchieve Conference

 

JERUSALEM, November 4, 2010 /PRNewswire-FirstCall/ -- Medisafe 1 Technologies Corp. (OTCBB: MFTH), a developer of patented technologies that physically prevent unauthorized administration of prescription medications, announced today that the company will present its barcoded syringe locking-device during the HealthAchieve Conference November 8-10, in Toronto, Canada.

The presentation is expected to take place on November 8th or 9th. Manufacturers of syringes and infusion technologies, pharmaceutical companies, health insurance companies, and public relations specialists will be in attendance.

HealthAchieve is one of the largest and most prestigious health care gatherings in North America. The conference features over 50 educational sessions, and more than 350 exhibitors. HealthAchieve attracts over 9,000 health care and business leaders from around the world. To learn more about HealthAchieve, visit http://www.healthachieve.com.

"To be accepted as a presenter at the prestigious HealthAchieve Conference demonstrates that health care professionals are interested in Medisafe's patented technology," said, Jacob Elhadad, CEO of Medisafe 1 Technologies. "Our syringe locking-device is capable of significantly reducing medication administration injuries and deaths. The market potential for such a product is quite extensive."

About Medisafe 1 Technologies

Medisafe 1 Technologies seeks to effectively prevent unauthorized administration of a drug or medicinal substance by hypodermic needle. Medisafe's patented technology is a medical assembly with a locking mechanism that is intended to ensure the substance cannot be released from the hypodermic needle without positive pre-matching between the substance and its intended patient.

Forward-Looking Statements

This letter contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 as amended and Section 21E of the Securities Exchange Act of 1934 as amended. All forward-looking statements are inherently uncertain, based on current expectations and assumptions concerning future events or future performance of Medisafe 1 Technologies Corp., and its technologies. In evaluating such statements, prospective investors should review carefully various risks and uncertainties identified in this release, as actual results may differ materially from those indicated. Medisafe 1 Technologies Corp. public filings may be viewed at http://www.sec.gov.

Contact: Jacob Elhadad CEO +972-524440000 jacob.elhadad10@gmail.com
'/>"/>

SOURCE Medisafe 1 Technologies Corp.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Medisafe 1 Technologies Successfully Tests Prototype of Patented Syringe Locking Device
2. Medisafe 1 Technologies Corp Notify Shareholders on FINRAs Approval of the 5-1 Stock Dividend
3. Medisafe 1 Technologies Clarifies the PR Issued on September 1 for the Stock Dividend, as a Forward Split of 5-1 in the Form of a Stock Dividend
4. Medisafe 1 Technologies Finalises Contract to Develop Prototype of the Worlds First Ever Medicinal Syringe-Locking Device
5. Medisafe 1 Technologies Granted Eligibility Status by the Depository Trust Company
6. Sandata Technologies Launches Enhanced Location Monitoring
7. Netsmart Technologies Software Supports Shawnee Mental Health Center Integrated Mental Health and Primary Care Initiative
8. BioSpecifics Technologies Corp. Awarded Two Qualifying Therapeutic Discovery Project Grants
9. IRS Awards $244,479 Grant to STB Lifesaving Technologies®
10. IDEV Technologies Announces FDA 510(k) Clearance for SUPERA VERITAS™
11. Patient Safety Technologies Appoints New Chief Financial Officer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/23/2017)... NEW YORK , Feb. 22, 2017 /PRNewswire/ ... dominate medical implant demand, as aging demographic patterns ... heart-related conditions. Implants for sports- and exercise-related injuries, ... artery disease will lead sales gains. The future ... The study addresses the following questions and more: ...
(Date:2/23/2017)... YORK , Feb. 22, 2017 ... the non-hodgkin lymphoma partnering deals and agreements entered ... Read the full report: http://www.reportlinker.com/p03605669-summary/view-report.html ... Agreements since 2010 report provides understanding and access ... the world,s leading healthcare companies. - ...
(Date:2/23/2017)... , February 23, 2017 - For ... ... Rare Disease Day Open to All at http://www.shire.com/RareCount   ... announced the launch of ,Rare Count, in honor of Rare Disease ... which equates to nearly one in 20 global citizens. It is ...
Breaking Medicine Technology:
(Date:2/23/2017)... California (PRWEB) , ... February 23, 2017 , ... ... Sports Development will host a diverse symposium on “Doping in Sport: ... Law and Sheppard Mullin Richter & Hampton LLP. The symposium will be held ...
(Date:2/23/2017)... ... February 23, 2017 , ... ... it will soon begin franchising throughout the U.S. starting this spring. Current Meditation ... the practice of meditation mainstream. Current Meditation will be the first meditation concept ...
(Date:2/23/2017)... CA (PRWEB) , ... February 23, 2017 , ... CALNOC, ... FACP, FACMPE, FACPE, will keynote their upcoming conference – Empowerment, Value and Collaboration – ... the chairman and CEO of the Virginia Mason Health System in Seattle since 2000. ...
(Date:2/23/2017)... ... 2017 , ... Thomas Vas-Don suffered from severe injury due to ... able to successfully recover. In “ Origin & Insertion Charts for Massage Therapists ” ... principals of massage, anatomy , trigger points and referral pain patterns . ...
(Date:2/22/2017)... ... February 22, 2017 , ... Gevir, a New Zealand-based company that ... its products are coming soon to Amazon.com, the world’s largest online retailer. ... means to develop an effective natural treatment for Shelley’s Multiple Sclerosis, which she’d been ...
Breaking Medicine News(10 mins):